HPC
VBIV

HM Payson & Co’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

HM Payson & Co’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10
Closed -$1K – 1169
2020
Q3 		$1K Hold
10
– – ﹤0.01% 1020
2020
Q2 		$1K Buy
+10
New +$551 ﹤0.01% 851

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HM Payson & Co's VBIV Position: Q4 2020 in Review

HM Payson & Co sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2020, closing a stake of 10 shares — an estimated $1K sold.

HM Payson & Co first reported a position in VBIV in Q2 2020 and held it in 2 quarters. The position peaked at $1K in Q3 2020. 122 funds tracked by Wall St. Rank hold VBIV as of Q4 2020.

  • HM Payson & Co reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2020 after selling out during the quarter.
  • HM Payson & Co sold 10 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2020, an estimated $1K.
  • HM Payson & Co first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and held it in 2 quarters.
  • HM Payson & Co's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $1K in Q3 2020.
  • 122 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2020.

Based on HM Payson & Co's 13F filing for Q4 2020, filed 10 Mar 2021.